A (b)(6) male patient with newly diagnosed glioblastoma (gbm) began optune therapy on (b)(6) 2019.On december 04, 2019, novocure was informed by the spouse that the patient had been hospitalized on an unspecified date a few weeks prior due to brain edema with associated confusion, decreased appetite, and vomiting.Optune therapy was discontinued.Per prescribing physician, patient had been hospitalized for headaches and treated with steroid medication.On an unspecified date, patient was discharged to an acute care facility.The prescriber stated that the cause of the events was a combination of treatment effect, gbm progression, and optune therapy.
|